Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Novartis is big time ….
They’re worth $236 billion market cap.
Maybe they’ll buy out this technology for around $3 billion.
Did they say when they’re releasing the Benzinga article? ….
Will it be the same day as IDE submission?
Right after IDE submission?
Or not until right after IDE approval?
etc.
That’s a very conservative PPS prediction ….
after IDE approval from the FDA (4 weeks from now).
How high do you think PPS will be 4 weeks from now?
Pete and Repeat were in a boat ….
Pete fell out.
Who was left?
lol, yeah ….
they’ve only said Q2 submission will happen 93 separate times.
But people are panicking because they didn’t say it 94 times.
Great news, thanks.
It feels like it will be June 28 - 30
for IDE submission at this point.
On Friday or this weekend.
But it could still be any day now.
Even today.
True ….
Benzinga does have millions of followers though.
But i totally agree.
Still a chance we can go green today ….
In the last 15 minutes.
IDE submission tweet may come out this evening. Realistic chance we will get that tweet.
Someone on the other forum ….
Said they spoke to Vivos today, and they were told when IDE is submitted it will be announced on X (Twitter).
MM’s are manipulating
Thanks
Yep, and don’t forget $RDGL ….
Cancer treatment stock that is working in a partnership with Mayo Clinic.
Up for FDA approval in the next few days.
Expected to be approved.
Should be a 10 bagger at least for RDGL.
Yep, and don’t forget this article as well ….
https://phys.org/news/2006-04-cancer-worth-trillion_1.amp
Vivos (RDGL) plans to be eventually approved to be performed on any and all tumors, of any type of cancer.
They did mention that they are targeting like 18 common types of cancer first. If anyone has that article, please post it again. Thanks.
https://www.sciencedaily.com/releases/2006/04/060426174214.htm
Next week is getting closer
Yep ….
And he might be willing to sell this technology for anything that would give him at least $5.00 per share, to give him $50 million for his 10 million shares.
Anything over $2 billion buyout, he might entertain and consider. That would be at around $5.00 per share.
He also might wait for a $4 billion buyout offer at minimum as well.
It’s in their best interest to get PPS as high as possible ….
If and when doing a future offering, they can raise more money for less shares.
So when selling 5 million shares at $1.50 offering = $7.5 million in funding. Only 5 million shares in that example get added to the 410 million O/S, therefore the change to the O/S doesn’t really change much from 410 million to 415 million, but over $7 million in funding is brought in. Win-win for them and for shareholders.
Also, it can’t hurt the buyout offer prices they get, the higher the PPS gets.
It’s in Vivos (and Korenko’s) best interest to get the PPS as high as possible.
I’d rather it be next week at this point.
Could be ….
My ultimate guess would be Monday.
And if not Monday, then on Thursday/Friday of next week.
if it breaks $0.25 today, how high can it go?
There are some really ignorant people on ST ….
“They only have like 7 people in the whole company”
You can’t write this stuff, wow.
The cancer industry, medical professionals, and big pharma are interested in the technology, not in their company headcount.
Vivos technology destroys tumors.
And does so without harming any surrounding tissue or inner body.
But wait, big pharma or the industry won’t be interested because they don’t have a company headcount big enough to have a Lunch Coordinator or Notes Receivable Specialist, or some other useless position in the company.
You don’t think we move past $0.31 on IDE submission news?
Tomorrow just feels like the day ….
that IDE gets submitted.
If so, today is possibly the last day to get these low prices.
5 million volume today?
I agree …..
I’m thinking $0.30 before submission.
3x to 5x shortly after submission ($0.90 - $1.50 range).
And who knows how high it can go after approval (I’m guessing $2.00 - $5.00 range).
Not to mention, George Sharp said this technology is worth billions, and has said that multiple times.
Bold prediction
I’m anticipating Friday or Monday
If not those two days, then it’ll probably be the last day (June 28).
When we break past $0.25 ….
I think it will go quite a bit higher.
That’s before IDE submission.
Lots of idiot flippers out there.
10 bagger
Average daily volume = 1.5 million
Over the past 30 days.
We are possibly going to hit that in the first hour today.
That is 7x our normal recent hourly volume average.
I still think there’s a possibility ….
That the “announcement” of submission and approval happens on the same day.
For example, Vivos may submit it on say Monday, June 24, and they don’t tell us on that day.
24 to 48 hours later, FDA approves it, since they already know what’s in it, and were helping Vivos through the whole process.
Then on Wednesday June 26, it gets announced that it was submitted that week, and the FDA just approved it.
I’m not saying this is a probability, I’m just saying it’s a possibility.
Yes sir ….
This appears to be a goldmine stock to own right now at this stage.
Yeah, the $9.00 is more realistic after successful human trials ….
$0.90 - $1.30 makes sense after IDE submission.
$2.00 - $4.99 makes sense soon/immediately after IDE approval, with $2.00 being more conservative, and near $5.00 being more closer to highest realistic amount then.
I can see a max of $2 billion market cap after IDE approval, but possibly closer to $1 billion more conservatively.
Should be $2.00 - $5.00 range after IDE approval ….
But because the approval is a very high probability after IDE submission, then I see $0.95 - $1.30 range on IDE submission news.
Who knows, this could go ballistic to $9.00 after the Benzinga article for all we know.
$0.75 is a very conservative prediction on IDE submission. This technology destroys tumors, and does so without harming any of the surrounding tissue or inner body.
$3 billion market cap (minimum)
At that point.
Divide that by 410 million O/S
= $7.31 (minimum)
Realistically it would probably hit $5 billion market cap or more however, so more than $10.00 per share is highly possible immediately after that.
Yep, because it will be higher than $2.50
Much higher.
Yep, they know what’s coming.